Tuesday, October 4, 2022


Biotechnology News Magazine

Synchrony Health Services launches Synchrony Lab

State of the art lab service designed to support long-term care communities

Latest Posts

BRAINBox Solutions Announces New U.S. Patent Allowance, Strengthening Biomarker Portfolio for Multi-Modal Mild Traumatic Brain Injury Test

BRAINBox Solutions notes the new patent covers both diagnosis of TBI and patient monitoring post-injury, particularly for determining return to work or play.

New Initiative Brings Leading Life Sciences Companies Together To Drive Collective Impact in Awareness, Diagnosis, Care, and Health Equity for Patients with Amyloidosis

Despite notable progress in recent years, amyloidosis patients continue to experience high unmet needs and gaps in treatment and support.

GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology

Steven Boyages, CEO of GBS Inc. stated, “We believe this acquisition generates significant value for our shareholders, and I am extremely excited to be on the forefront of this transition. Bringing IFP under the GBS umbrella marks a significant advancement toward achieving our strategic goals of improving patients’ lives outside of saliva-based glucose testing and laying the pathway in becoming a leader in the development of rapid, non-invasive diagnostic solutions. We remain excited to accelerate our strategy and revenue growth through this collaboration with IFP.”

Araris Biotech Closes $24 Million Financing Round

Araris Biotech notes the proceeds from the financing will be used to support the further development and advancement of Araris’ antibody-drug conjugate (ADC) candidates, created using the Company’s proprietary linker technology, as Araris moves closer toward clinical development.

Synchrony Health Services is excited to announce the official launch of its latest division, Synchrony Lab.

Housed in Louisville, Kentucky, the lab will use the latest technology to provide testing and diagnostics specifically for residents of long-term care communities. Lab services will be offered six days a week and will offer a quicker turnaround time, with most routine results coming back in 12-18 hours.

“Today is an exciting day not only for our company but for the customers we serve,” Randy Bufford, President and CEO of Synchrony Health Services said. “By offering lab services six days a week with swift turnaround times, we are leveraging state-of-the-art technology and logistics to provide actionable and accurate clinical data in a timely fashion to the practitioners we are serving.”

“We have planned and customized our lab to operate with the highest quality – with a focus on providing the best care for the senior housing community. We are so excited to launch our services and to watch how patient care is improved by our laboratory,” Dr. Lori Millner, Synchrony Lab Director said.

Synchrony Lab offers improved electronic health record integrations for seamless service that allows all orders to be placed and results to be reviewed timely within the same system.

By September of 2022, Synchrony Lab will serve an estimated 130 long-term health care communities.

Synchrony Health Services includes Synchrony Pharmacy, Synchrony Rehabilitation, SynchronyRx@HOME, and Synchrony Lab under its umbrella.  Synchrony Health Services was created during 2019 to capture clinical excellence obtained through collaboration and coordination.

Synchrony Lab was launched in March 2022. This division will provide routine and stat labs including chemistry, hematology, coagulation, urinalysis, microbiology, and molecular testing within the long-term care setting. The company will bring superior clinical data to its clients through the availability of accurate testing, responsive turnaround times, and electronic health record integration for their customers.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine